Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management

An integrated encyclopedia of DNA elements in the human genome

The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072

Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity

Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,868

DNA methylation landscapes: Provocative insights from epigenomics

Suzuki, M. M., & Bird, A. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2341 · Cited by 3,039

The ENCODE (ENCyclopedia Of DNA Elements) Project

(2004) · Science · doi:10.1126/science.1105136 · Cited by 2,390

Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells

Lister, R., Pelizzola, M., Kida, Y. S., Hawkins, R. D., Nery, J. R., Hon, G. C., Antosiewicz‐Bourget, J., O’Malley, R. C., Castanon, R., Klugman, S. A., et al. (2011) · Nature · doi:10.1038/nature09798 · Cited by 1,595

Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies

Octavia, Y., Tocchetti, C. G., Gabrielson, K. L., Janssens, S. P., Crijns, H. J. G. M., & Moens, A. L. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.03.006 · Cited by 1,425

Nitric Oxide Synthases: Properties and Catalytic Mechanism

Griffith, O. W., & Stuehr, D. J. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.003423 · Cited by 1,311

Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation

Ichikawa, Y., Ghanefar, M., Bayeva, M., Wu, R., Khechaduri, A., Prasad, S. V. N., Mutharasan, R. K., Naik, T. J., & Ardehali, H. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72931 · Cited by 881

The biosynthesis and functional role of cardiolipin

Schlame, M., Rua, D., & Greenberg, M. L. (2000) · Progress in Lipid Research · doi:10.1016/s0163-7827(00)00005-9 · Cited by 810

Epigenetics: Definition, Mechanisms and Clinical Perspective

Dupont, C., Armant, D. R., & Brenner, C. A. (2009) · Seminars in Reproductive Medicine · doi:10.1055/s-0029-1237423 · Cited by 804

Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron

Šimůnek, T., Štěrba, M., Popelová, O., Adamcová, M., Hrdina, R., & Geršl, V. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70018-0 · Cited by 770

Non-coding RNAs as regulators of gene expression and epigenetics

Kaikkonen, M. U., Lam, M. T. Y., & Glass, C. K. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr097 · Cited by 764

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Curigliano, G., Cardinale, D. M., Dent, S. F., Criscitiello, C., Aseyev, O., Lenihan, D. J., & Cipolla, C. M. (2016) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21341 · Cited by 761

Protective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy

Kalay, N., Başar, E., Özdoğru, İ., Er, O. S., Çetinkaya, Y., Doğan, A., Oğuzhan, A., Eryol, N. K., Topsakal, R., Ergin, A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.052 · Cited by 708

Molecular mechanism of doxorubicin-induced cardiomyopathy – An update

Renu, K., Gopalakrishnan, A. V., Pichiah, P. B. T., & Arunachalam, S. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.10.043 · Cited by 599

Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin

Frederick, C. A., Williams, L. D., Ughetto, G., MAREL, G. A. V. D., BOOM, J. H. V., Rich, A., & Wang, A. H. ‐. (1990) · Biochemistry · doi:10.1021/bi00462a016 · Cited by 578

The anthracyclines: will we ever find a better doxorubicin?

Weiss, R. B. (1992) · PubMed · Cited by 558

DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria

Shock, L. S., Thakkar, P. V., Peterson, E. J., Moran, R. G., & Taylor, S. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012311108 · Cited by 555

Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention

Henriksen, P. A. (2017) · Heart · doi:10.1136/heartjnl-2017-312103 · Cited by 554

Energy metabolism in heart failure

Ventura‐Clapier, R., Garnier, A., & Veksler, V. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.055095 · Cited by 514

The apoptotic signaling pathway activated by Toll‐like receptor‐2

Aliprantis, A. O., Yang, R., Weiss, D. S., Godowski, P., & Zychlinsky, A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3325 · Cited by 502

NAD(P)H Oxidase and Multidrug Resistance Protein Genetic Polymorphisms Are Associated With Doxorubicin-Induced Cardiotoxicity

Wojnowski, L., Kulle, B., Schirmer, M., Schlüter, G., Schmidt, A. G., Rosenberger, A., Vonhof, S., Bickeböller, H., Toliat, M. R., Suk, E.-K., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.576850 · Cited by 493

Anthracycline Cardiotoxicity: From Bench to Bedside

Gianni, L., Herman, E. H., Lipshultz, S. E., Minotti, G., Sarvazyan, N. A., & Sawyer, D. B. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.9401 · Cited by 458

Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells.

Fornari, F. A., Randolph, J. K., Yalowich, J. C., Ritke, M. K., & Gewirtz, D. A. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10149-1 · Cited by 436

Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin

Pang, B., Qiao, X., Janssen, L., Velds, A., Groothuis, T. A., Kerkhoven, R. M., Nieuwland, M., Ovaa, H., Rottenberg, S., van Tellingen, O., et al. (2013) · Nature Communications · doi:10.1038/ncomms2921 · Cited by 431

Transcriptional and Posttranscriptional Regulation of Endothelial Nitric Oxide Synthase Expression by Hydrogen Peroxide

Drummond, G. R., Cai, H., Davis, M. E., Ramasamy, S., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.86.3.347 · Cited by 430

Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells.

Momparler, R. L., Karon, M. R., Siegel, S. E., & Avila, F. (1976) · PubMed · Cited by 423

One-Carbon Metabolism: Linking Nutritional Biochemistry to Epigenetic Programming of Long-Term Development

Clare, C., Brassington, A. H., Kwong, W. Y., & Sinclair, K. D. (2018) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-020518-115206 · Cited by 423

Clinical Pharmacokinetics of Doxorubicin

Speth, P. A. J., van Hoesel, Q. G. C. M., & Haanen, C. (1988) · Clinical Pharmacokinetics · doi:10.2165/00003088-198815010-00002 · Cited by 422

Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes

Zhao, L., & Zhang, B. (2017) · Scientific Reports · doi:10.1038/srep44735 · Cited by 393

Adiponectin: Role in Physiology and Pathophysiology

Nguyen, T. M. D. (2020) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_193_20 · Cited by 390

Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's Sarcoma

Northfelt, D., Martin, F. J., Working, P. K., Volberding, P. A., Russell, J., Newman, M., Amantea, M., & Kaplan, L. D. (1996) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1996.tb04152.x · Cited by 377

Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro

Mukhopadhyay, P., Rajesh, M., Bátkai, S., Kashiwaya, Y., Haskó, G., Liaudet, L., Szabó, C., & Pacher, P. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00795.2008 · Cited by 377

Endothelial Nitric Oxide Synthase-Dependent Superoxide Generation from Adriamycin

Vasquez-Vivar, J. M., Pavel Martasek, E., Hogg, N., Masters, B. S. S., Pritchard, K. A., & Kalyanaraman, B. (1997) · Biochemistry · doi:10.1021/bi971475e · Cited by 366

Phosphodiesterase-5 Inhibition With Sildenafil Attenuates Cardiomyocyte Apoptosis and Left Ventricular Dysfunction in a Chronic Model of Doxorubicin Cardiotoxicity

Fisher, P. W., Salloum, F. N., Das, A., Hyder, H., & Kukreja, R. C. (2005) · Circulation · doi:10.1161/01.cir.0000160359.49478.c2 · Cited by 350

Curcumin

Lestari, M. L. A. D., & Indrayanto, G. (2014) · Profiles of drug substances, excipients, and related methodology · doi:10.1016/b978-0-12-800173-8.00003-9 · Cited by 350

Metformin alleviates oxidative stress and enhances autophagy in diabetic kidney disease via AMPK/SIRT1-FoxO1 pathway

Ren, H., Shao, Y., Wu, C., Ma, X., Lv, C., & Wang, Q. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110628 · Cited by 313

Doxorubicin induced heart failure: Phenotype and molecular mechanisms

Mitry, M. A., & Edwards, J. G. (2015) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2015.11.004 · Cited by 312

Evidence of a specific complex between adriamycin and negatively-charged phospholipids

Goormaghtigh, E., Chatelain, P., Caspers, J., & Ruysschaert, J. (1980) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(80)90145-5 · Cited by 310

Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin.

Zhou, S., Starkov, A. A., Froberg, M. K., Leino, R. L., & Wallace, K. B. (2001) · PubMed · Cited by 310

Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity

Koleini, N., & Kardami, E. (2017) · Oncotarget · doi:10.18632/oncotarget.16944 · Cited by 308

Anthracyclines Induce Calpain-dependent Titin Proteolysis and Necrosis in Cardiomyocytes

Lim, C. C., Zuppinger, C., Guo, X., Kuster, G. M., Helmes, M., Eppenberger, H. M., Suter, T. M., Liao, R., & Sawyer, D. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308033200 · Cited by 303

Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity

Aries, A., Paradis, P., Lefèbvre, C., Schwartz, R. J., & Nemer, M. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401833101 · Cited by 299

Transcription Factor GATA4 Inhibits Doxorubicin-induced Autophagy and Cardiomyocyte Death

Kobayashi, S., Volden, P. A., Timm, D. J., Mao, K., Xu, X., & Liang, Q. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.070037 · Cited by 288

Activation of nuclear factor-κB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide

Wang, S., Kotamraju, S., Konorev, E. A., Kalivendi, S. V., Joseph, J., & Kalyanaraman, B. (2002) · Biochemical Journal · doi:10.1042/bj20020752 · Cited by 286

Probucol Protects Against Adriamycin Cardiomyopathy Without Interfering With Its Antitumor Effect

Iliskovic, N., Hill, M. D., Chow, D. A., & Singal, P. K. (1995) · Circulation · doi:10.1161/01.cir.91.1.10 · Cited by 282

Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats.

Iliskovic, N., Kaul, N., & Singal, P. K. (1994) · Circulation · doi:10.1161/01.cir.89.6.2829 · Cited by 265

Statins Activate AMP-Activated Protein Kinase In Vitro and In Vivo

Sun, W., Lee, T., Zhu, M., Gu, C., Wang, Y., Zhu, Y., & Shyy, J. Y.-J. (2006) · Circulation · doi:10.1161/circulationaha.106.630194 · Cited by 264

Epigenetics: interaction of DNA methylation and chromatin

Nakao, M. (2001) · Gene · doi:10.1016/s0378-1119(01)00721-1 · Cited by 251

Nox2 NADPH Oxidase Promotes Pathologic Cardiac Remodeling Associated with Doxorubicin Chemotherapy

Zhao, Y., McLaughlin, D., Robinson, E., Harvey, A., Hookham, M. B., Shah, A. M., McDermott, B. J., & Grieve, D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2664 · Cited by 245

Hsp10 and Hsp60 modulate Bcl-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac muscle cells

Shan, Y. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00229-3 · Cited by 235

Molecular Basis of Anthracycline-Induced Cardiotoxicity and Its Prevention

Horenstein, M. S., Heide, R. S. V., & L’Ecuyer, T. J. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3043 · Cited by 231

Acute Doxorubicin Cardiotoxicity Is Associated With p53-Induced Inhibition of the Mammalian Target of Rapamycin Pathway

Zhu, W., Soonpaa, M. H., Chen, H., Shen, W., Payne, R. M., Liechty, E. A., Caldwell, R. L., Shou, W., & Field, L. J. (2008) · Circulation · doi:10.1161/circulationaha.108.799700 · Cited by 229

New anthracycline antibiotics.

OKI, T. (1977) · PubMed · Cited by 227

Doxorubicin-induced Apoptosis Is Associated with Increased Transcription of Endothelial Nitric-oxide Synthase

Kalivendi, S. V., Kotamraju, S., Zhao, H., Joseph, J., & Kalyanaraman, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106829200 · Cited by 225

Updates in Anthracycline-Mediated Cardiotoxicity

Nebigil, C. G., & Désaubry, L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01262 · Cited by 219

Intravenous administration of mitochondria for treating experimental Parkinson's disease

Shi, X., Zhao, M., Fu, C., & Fu, A. (2017) · Mitochondrion · doi:10.1016/j.mito.2017.02.005 · Cited by 218

Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway

Horie, T., Ono, K., Nishi, H., Nagao, K., Kinoshita, M., Watanabe, S., Kuwabara, Y., Nakashima, Y., Takanabe‐Mori, R., Nishi, E., et al. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq148 · Cited by 212

Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium

Kalivendi, S. V., Konorev, E. A., Cunningham, S., Vanamala, S. K., Kaji, E. H., Joseph, J., & Kalyanaraman, B. (2005) · Biochemical Journal · doi:10.1042/bj20050285 · Cited by 209

Malate dehydrogenase isoenzymes: Cellular locations and role in the flow of metabolites between the cytoplasm and cell organelles

Gietl, C. (1992) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0167-4838(92)90476-t · Cited by 205

Anthracycline-Induced Cardiotoxicity: A Review of Pathophysiology, Diagnosis, and Treatment

Raj, S., Franco, V. I., & Lipshultz, S. E. (2014) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-014-0315-4 · Cited by 200

Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy.

Minotti, G., Ronchi, R., Salvatorelli, E., Menna, P., & Cairo, G. (2001) · PubMed · Cited by 199

New signal transduction paradigms in anthracycline-induced cardiotoxicity

Ghigo, A., Li, M., & Hirsch, E. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.01.021 · Cited by 196

Basic concepts of epigenetics

Inbar‐Feigenberg, M., Choufani, S., Butcher, D. T., Roifman, M., & Weksberg, R. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.01.117 · Cited by 193

miR-199a impairs autophagy and induces cardiac hypertrophy through mTOR activation

Li, Z., Song, Y., Liu, L., Hou, N., An, X., Zhan, D., Li, Y., Zhou, L., Li, P., Yu, L., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.95 · Cited by 192

The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity

Timm, K. N., & Tyler, D. J. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-06941-x · Cited by 192

Doxorubicin Induces Apoptosis by Activation of Caspase-3 in Cultured Cardiomyocytes In Vitro and Rat Cardiac Ventricles In Vivo

Ueno, M., Kakinuma, Y., Yuhki, K., Murakoshi, N., Iemitsu, M., Miyauchi, T., & Yamaguchi, I. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0050980 · Cited by 189

Extracellular Heat Shock Protein 60, Cardiac Myocytes, and Apoptosis

Kim, S.-C., Stice, J. P., Chen, L., Jung, J. S., Gupta, S., Wang, Y., Baumgarten, G., Trial, J., & Knowlton, A. A. (2009) · Circulation Research · doi:10.1161/circresaha.109.209643 · Cited by 188

Effects by doxorubicin on the myocardium are mediated by oxygen free radicals

Xu, M. F., Tang, P. L., Qian, Z., & Ashraf, M. (2001) · Life Sciences · doi:10.1016/s0024-3205(00)00990-5 · Cited by 186

Curcumin suppresses doxorubicin-induced cardiomyocyte pyroptosis via a PI3K/Akt/mTOR-dependent manner

Yu, W., Qin, X., Zhang, Y., Qiu, P., Wang, L., Zha, W., & Ren, J. T. (2020) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-19-707 · Cited by 184

Mitochondrial catastrophe during doxorubicin‐induced cardiotoxicity: a review of the protective role of melatonin

Govender, J., Loos, B., Marais, E., & Engelbrecht, A. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12176 · Cited by 182

Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase

SPALLAROSSA, P., ALTIERI, P., GARIBALDI, S., GHIGLIOTTI, G., BARISIONE, C., MANCA, V, FABBI, P., BALLESTRERO, A., BRUNELLI, C., & BARSOTTI, A. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.08.009 · Cited by 182

Preventive effect of naringin on cardiac markers, electrocardiographic patterns and lysosomal hydrolases in normal and isoproterenol-induced myocardial infarction in Wistar rats

Rajadurai, M., & Prince, P. S. M. (2006) · Toxicology · doi:10.1016/j.tox.2006.11.053 · Cited by 180

Heat Shock Protein 20 Interacting With Phosphorylated Akt Reduces Doxorubicin-Triggered Oxidative Stress and Cardiotoxicity

Fan, G., Zhou, X., Wang, X., Song, G., Qian, J., Nicolaou, P. A., Chen, G., Ren, X., & Kranias, E. G. (2008) · Circulation Research · doi:10.1161/circresaha.108.182832 · Cited by 178

Conditional Cardiac Overexpression of Endothelin-1 Induces Inflammation and Dilated Cardiomyopathy in Mice

Yang, L. L., Gros, R., Kabir, M. G., Sadi, A.-M., Gotlieb, A. I., Husain, M., & Stewart, D. J. (2004) · Circulation · doi:10.1161/01.cir.0000105701.98663.d4 · Cited by 177

The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein‐1 in cytosolic fractions from human myocardium

Minotti, G., Recalcati, S., Mordente, A., Liberi, G., Calafiore, A. M., Mancuso, C., Preziosi, P., & Cairo, G. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.7.541 · Cited by 172

Emerging Paradigms in Cardiomyopathies Associated With Cancer Therapies

Ky, B., Vejpongsa, P., Yeh, E. T. H., Force, T. L., & Moslehi, J. J. (2013) · Circulation Research · doi:10.1161/circresaha.113.300218 · Cited by 171

Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin

Miranda, C. J., Makui, H., Soares, R., Bilodeau, M., Mui, J., Vali, H., Bertrand, R., Andrews, N. C., & Santos, M. M. (2003) · Blood · doi:10.1182/blood-2003-03-0869 · Cited by 170

Anticancer property of ginsenoside Rh2 from ginseng

Li, X., Chu, S., Lin, M., Gao, Y., Liu, Y., Yang, S., Zhou, X., Zhang, Y., Hu, Y., Wang, H., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112627 · Cited by 170

Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis

Abdel‐Daim, M. M., Kilany, O. E., Khalifa, H. A., & Ahmed, A. A. M. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3413-7 · Cited by 166

Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction

Das, A., Durrant, D., Mitchell, C., Mayton, E. K., Hoke, N. N., Salloum, F. N., Park, M. A., Qureshi, I. Z., Lee, R., Dent, P., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006965107 · Cited by 160

Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission

Liang, X., Wang, S., Wang, L., Ceylan, A. F., Ren, J. T., & Zhang, Y. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104846 · Cited by 160

Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage

Tatlıdede, E., Şehırlı, Ö., Velioğlu‐Öğünç, A., Çetınel, Ş., Yeğen, B. Ç., Yarat, A., Süleymanoğlu, S., & Şener, G. (2009) · Free Radical Research · doi:10.1080/10715760802673008 · Cited by 156

Differential roles of caspase-1 and caspase-11 in infection and inflammation

Man, S. M., Karki, R., Briard, B., Burton, A. R., Gingras, S., Pelletier, S. W., & Kanneganti, T. (2017) · Scientific Reports · doi:10.1038/srep45126 · Cited by 155

Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis

Dargani, Z. T., & Singla, D. K. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00056.2019 · Cited by 153

LCZ696 improves cardiac function via alleviating Drp1-mediated mitochondrial dysfunction in mice with doxorubicin-induced dilated cardiomyopathy

Xia, Y., Chen, Z., Chen, A., Fu, M., Dong, Z., Hu, K., Yang, X., Zou, Y., Sun, A., Qian, J., et al. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.06.003 · Cited by 142

NADPH oxidases participate to doxorubicin-induced cardiac myocyte apoptosis

Gilleron, M., Marechal, X., Montaigne, D., Franczak, J., Nevière, R., & Lancel, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.085 · Cited by 141

Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase

Liu, Y., Asnani, A. H., Zou, L., Bentley, V. L., Yu, M., Wang, Y., Dellaire, G., Sarkar, K. S., Dai, M. S., Chen, H. H., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3010189 · Cited by 139

Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy

Bartlett, J. J., Trivedi, P. C., Yeung, P. K. F., Kienesberger, P. C., & Pulinilkunnil, T. (2016) · Biochemical Journal · doi:10.1042/bcj20160385 · Cited by 138

Attenuation of Doxorubicin-Induced Cardiotoxicity by mdivi-1: A Mitochondrial Division/Mitophagy Inhibitor

Gharanei, M., Hussain, A., Janneh, O., & Maddock, H. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077713 · Cited by 135

Lipid peroxidation and possible hydroxyl radical formation stimulated by the self-reduction of a doxorubicin-iron (III) complex

Gutteridge, J. M. C. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90340-x · Cited by 133

Emerging role of oxidative stress in metabolic syndrome and cardiovascular diseases: important role of Rac/ NADPH oxidase

Elnakish, M. T., Hassanain, H. H., Janssen, P. M. L., Angelos, M. G., & Khan, M. (2013) · The Journal of Pathology · doi:10.1002/path.4255 · Cited by 133

Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways

Ma, J., Wang, Y., Zheng, D., Meng, W., Xu, H., & Peng, T. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs309 · Cited by 132

Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy

Carvalho, R. A., Sousa, R. P. B., Cadete, V. J. J., Lopaschuk, G. D., Palmeira, C. M., Bjork, J. A., & Wallace, K. B. (2010) · Toxicology · doi:10.1016/j.tox.2010.01.019 · Cited by 131

Renal erythropoietin-producing cells in health and disease

Souma, T., Suzuki, N., & Yamamoto, M. P. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00167 · Cited by 129

Extracellular Release of the Atheroprotective Heat Shock Protein 27 Is Mediated by Estrogen and Competitively Inhibits acLDL Binding to Scavenger Receptor-A

Rayner, K. J., Chen, Y.-X., McNulty, M. S., Simard, T., Zhao, X., Wells, D. J., de Belleroche, J., & O’Brien, E. R. (2008) · Circulation Research · doi:10.1161/circresaha.108.172155 · Cited by 128

Metformin Protects Cardiomyocyte from Doxorubicin Induced Cytotoxicity through an AMP-Activated Protein Kinase Dependent Signaling Pathway: An In Vitro Study

Kobashigawa, L. C., Xu, Y. C., Padbury, J. F., Tseng, Y., & Yano, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104888 · Cited by 127

Doxorubicin treatment in vivo activates caspase‐12 mediated cardiac apoptosis in both male and female rats

Jang, Y. M., Kendaiah, S., Drew, B., Phillips, T., Selman, C., Julian, D. A., & Leeuwenburgh, C. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.10.053 · Cited by 126

Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis

Roca-Alonso, L., Castellano, L., Mills, A. M., Dabrowska, A. F., Sikkel, M. B., Pellegrino, L., Jacob, J., Frampton, A. E., Krell, J., Coombes, R. C., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.89 · Cited by 120

Luteolin Attenuates Doxorubicin-Induced Cardiotoxicity Through Promoting Mitochondrial Autophagy

Xu, H., Yu, W., Sun, S., Li, C., Zhang, Y., & Ren, J. T. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00113 · Cited by 120

Pharmacokinetics of anticancer agents in patients with impaired liver function

Donelli, M. G., Zucchetti, M., Munzone, E., D’Incalci, M., & Crosignani, A. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00340-7 · Cited by 119

Ghrelin prevents doxorubicin-induced cardiotoxicity through TNF-alpha/NF-κB pathways and mitochondrial protective mechanisms

Xu, Z., Lin, S., Wu, W.-K., Tan, H., Wang, Z., Cheng, C., Lu, L., & Zhang, X. (2008) · Toxicology · doi:10.1016/j.tox.2008.02.018 · Cited by 116

Activation of AMP-Activated Protein Kinase Contributes to Doxorubicin-Induced Cell Death and Apoptosis in Cultured Myocardial H9c2 Cells

Chen, M., Wu, X., Gu, J., Guo, Q.-T., Shen, W., & Lu, P. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9153-0 · Cited by 115

The Endothelin Receptor Blocker Bosentan Inhibits Doxorubicin-Induced Cardiomyopathy

Bien, S., Riad, A., Ritter, C. A., Gratz, M., Olshausen, F., Westermann, D., Grube, M., Krieg, T., Ciecholewski, S., Felix, S. B., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1344 · Cited by 110

Gp91phox-containing NAD(P)H oxidase increases superoxide formation by doxorubicin and NADPH

Deng, S., Kruger, A., Kleschyov, A. L., Kalinowski, L., Daiber, A., & Wojnowski, L. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.11.013 · Cited by 109

Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients

Ruggeri, C., Gioffré, S., Achilli, F., Colombo, G. I., & D’Alessandra, Y. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9653-0 · Cited by 107

MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2

Tong, Z., Jiang, B., Wu, Y., Liu, Y., Li, Y., Gao, M., Jiang, Y., Lv, Q., & Xiao, X. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160714511 · Cited by 102

Impact of Frequency of Multi-Vitamin/Multi-Mineral Supplement Intake on Nutritional Adequacy and Nutrient Deficiencies in U.S. Adults

Blumberg, J., Frei, B., Fulgoni, V., Weaver, C., & Zeisel, S. (2017) · Nutrients · doi:10.3390/nu9080849 · Cited by 99

Echinochrome A Protects Mitochondrial Function in Cardiomyocytes against Cardiotoxic Drugs

Jeong, S., Kim, H. K., Song, I.-S., Lee, S., Ko, K. S., Rhee, B. D., Kim, N., Mishchenko, N. P., Fedoryev, S., Stonik, V. A., et al. (2014) · Marine Drugs · doi:10.3390/md12052922 · Cited by 96

5-FU induced cardiotoxicity: case series and review of the literature

Yuan, C., Parekh, H. D., Allegra, C. J., George, T. J., & Starr, J. S. (2019) · Cardio-Oncology · doi:10.1186/s40959-019-0048-3 · Cited by 95

Perturbation of microRNAs in Rat Heart during Chronic Doxorubicin Treatment

Vacchi‐Suzzi, C., Bauer, Y., Berridge, B. R., Bongiovanni, S., Gerrish, K., Hamadeh, H. K., Letzkus, M., Lyon, J. J., Moggs, J. G., Paules, R. S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040395 · Cited by 94

Anthracycline Antibiotics

Fujiwara, A., Hoshino, T., & WESTLEY, J. W. (1985) · Critical Reviews in Biotechnology · doi:10.3109/07388558509150782 · Cited by 92

Resveratrol in prostate diseases - a short review

Jasiński, M., Jasińska, L., & Ogrodowczyk, M. (2013) · Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication · doi:10.5173/ceju.2013.02.art8 · Cited by 88

L-type cardiac calcium channels in doxorubicin cardiomyopathy in rats morphological, biochemical, and functional correlations.

Keung, E. C., Toll, L., Ellis, M., & Jensen, R. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115241 · Cited by 86

PGC1α activation by pterostilbene ameliorates acute doxorubicin cardiotoxicity by reducing oxidative stress via enhancing AMPK and SIRT1 cascades

Liu, D., Ma, Z., Xu, L., Zhang, X., Qiao, S., & Yuan, J. (2019) · Aging · doi:10.18632/aging.102418 · Cited by 86

MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction

Tony, H., Yu, K., & Qiutang, Z. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/597032 · Cited by 80

Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity

Ferreira, A., Cunha‐Oliveira, T., Simões, R. F., Carvalho, F. S., Burgeiro, A., Nordgren, K. K. S., Wallace, K. B., & Oliveira, P. J. (2017) · Toxicology · doi:10.1016/j.tox.2017.08.011 · Cited by 78

The Role of Antioxidants in Ameliorating Cyclophosphamide-Induced Cardiotoxicity

Ayza, M. A., Zewdie, K. A., Tesfaye, B. A., Wondafrash, D. Z., & Berhe, A. H. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4965171 · Cited by 78

p53 Regulates Oxidative Stress-Mediated Retrograde Signaling: A Novel Mechanism for Chemotherapy-Induced Cardiac Injury

Velez, J. M., Miriyala, S., Nithipongvanitch, R., Noel, T. J., Plabplueng, C. D., Oberley, T. D., Jungsuwadee, P., Remmen, H. V., Vore, M. E., & Clair, D. K. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018005 · Cited by 73

Doxorubicin-Induced Cardiotoxicity: From Mechanisms to Development of Efficient Therapy

dos Santos, D. S., & Goldenberg, R. C. D. S. (2018) · InTech eBooks · doi:10.5772/intechopen.79588 · Cited by 73

HDAC6 inhibition protects cardiomyocytes against doxorubicin-induced acute damage by improving α-tubulin acetylation

Song, R. Y., Yang, Y., Han, L., Wang, G., Huang, Y. C., Xue, W., Wang, Y., Yao, L., & Zhu, Y. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.10.007 · Cited by 70

Role of heat shock factor-1 activation in the doxorubicin-induced heart failure in mice

Vedam, K., Nishijima, Y., Druhan, L. J., Khan, M., Moldovan, N. I., Zweier, J. L., & Ilangovan, G. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01047.2009 · Cited by 69

Interaction of anthracyclines with iron responsive element mRNAs

Canzoneri, J. C., & Oyelere, A. K. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn774 · Cited by 67

Metabolic fingerprint of ischaemic cardioprotection: importance of the malate-aspartate shuttle

Nielsen, T. T., Støttrup, N. B., Løfgren, B., & Bøtker, H. E. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr051 · Cited by 64

Chrysophanol protects against doxorubicin-induced cardiotoxicity by suppressing cellular PARylation

Lü, J., Li, J., Hu, Y., Guo, Z., Sun, D., Wang, P., Guo, K., Duan, D. D., Gao, S., Jiang, J., et al. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.10.008 · Cited by 64

Telomerase therapy attenuates cardiotoxic effects of doxorubicin

Chatterjee, S., Hofer, T., Costa, A., Lu, D., Batkai, S., Gupta, S. K., Bolesani, E., Zweigerdt, R., Megias, D., Streckfuss-Bömeke, K., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.035 · Cited by 63

Regulation of Rac1 by Simvastatin in Endothelial Cells

Kou, R., Sartoretto, J. L., & Michel, T. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808664200 · Cited by 62

Cardioprotective Effects of 20(S)-Ginsenoside Rh2 against Doxorubicin-Induced Cardiotoxicity In Vitro and In Vivo

Wang, H., Yu, P., Gou, H., Zhang, J., Zhu, M. J., Wang, Z., Tian, J., Jiang, Y., & Fu, F. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/506214 · Cited by 60

Plantainoside D protects adriamycin-induced apoptosis in H9c2 cardiac muscle cells via the inhibition of ROS generation and NF-κB activation

Kim, D., Woo, E., Chae, S., Ha, K.-C., Lee, G., Hong, S., Kwon, D., Kim, M., Jung, Y., Kim, H., et al. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.09.019 · Cited by 60

CaMKII activation participates in doxorubicin cardiotoxicity and is attenuated by moderate GRP78 overexpression

Tscheschner, H., Meinhardt, E., Schlegel, P., Jungmann, A., Lehmann, L., Müller, O. J., Most, P., Katus, H. A., & Raake, P. W. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215992 · Cited by 60

Epoetin Alfa in Patients With Advanced-Stage Hodgkin's Lymphoma: Results of the Randomized Placebo-Controlled GHSG HD15EPO Trial

Engert, A., Josting, A., Haverkamp, H., Villalobos, M., Lohri, A., Sökler, M., Zijlstra, J. M., Sturm, I., Topp, M. S., Rank, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.1835 · Cited by 59

Autophagy: an adaptive physiological countermeasure to cellular senescence and ischaemia/reperfusion‐associated cardiac arrhythmias

Lekli, I., Haines, D. D., Balla, G., & Tósaki, Á. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13053 · Cited by 57

Schisandrin B Prevents Doxorubicin-Induced Chronic Cardiotoxicity and Enhances Its Anticancer Activity In Vivo

Xu, Y., Liu, Z., Sun, J., Pan, Q., Sun, F., Yan, Z., & Hu, X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028335 · Cited by 55

Targeting Extracellular Heat Shock Protein 70 Ameliorates Doxorubicin‐Induced Heart Failure Through Resolution of Toll‐Like Receptor 2–Mediated Myocardial Inflammation

Liu, P., Bao, H., Jin, C., Zhou, J., Hua, F., Li, K., Lv, X., Cui, B., Hu, Z., & Zhang, X. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012338 · Cited by 55

Thymoquinone attenuates doxorubicin‐cardiotoxicity in rats

Karabulut, D., Öztürk, E., Kaymak, E., Akın, A. T., & Yakan, B. (2020) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22618 · Cited by 55

An Oral Selective Alpha-1A Adrenergic Receptor Agonist Prevents Doxorubicin Cardiotoxicity

Beak, J. Y., Huang, W., Parker, J. S., Hicks, S. T., Patterson, C., Simpson, P. C., Ma, A., Jin, J. J., & Jensen, B. C. (2017) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2016.10.006 · Cited by 54

Chia Seed Oil Ameliorates Doxorubicin-Induced Cardiotoxicity in Female Wistar Rats: An Electrocardiographic, Biochemical and Histopathological Approach

Ahmed, A. Z., Mumbrekar, K. D., Satyam, S. M., Shetty, P., D’Souza, M. R., & Singh, V. K. (2021) · Cardiovascular Toxicology · doi:10.1007/s12012-021-09644-3 · Cited by 54

Schisandrin B Prevents Doxorubicin-Induced Cardiotoxicity via Enhancing Glutathione Redox Cycling

Li, L., Pan, Q., Han, W., Liu, Z., Li, L., & Hu, X. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1579 · Cited by 53

Methyl Gallate Attenuates Doxorubicin-Induced Cardiotoxicity in Rats by Suppressing Oxidative Stress

Ahmed, A. Z., Satyam, S. M., Shetty, P., & D’Souza, M. R. (2021) · Scientifica · doi:10.1155/2021/6694340 · Cited by 53

Doxorubicin-induced nitrosative stress is mitigated by vitamin C via the modulation of nitric oxide synthases

Akolkar, G., Bagchi, A. K., Ayyappan, P., Jassal, D. S., & Singal, P. K. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00356.2016 · Cited by 52

Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase‐induced cardiomyopathy: involvement of mitofusin‐2

McLaughlin, D., Zhao, Y., O’Neill, K. M., Edgar, K. S., Dunne, P. D., Kearney, A. M., Grieve, D., & McDermott, B. J. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13773 · Cited by 52

Proanthocyanidin alleviates doxorubicin‐induced cardiac injury by inhibiting NF‐ k B pathway and modulating oxidative stress, cell cycle, and fibrogenesis

Sadek, K. M., Mahmoud, S. F. E., Zeweil, M. F., & Abouzed, T. K. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22716 · Cited by 52

Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity

Kumari, H., Huang, W.-H., & Chan, M. W. Y. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00056 · Cited by 51

Management of Blood Cholesterol

Alenghat, F. J., & Davis, A. M. (2019) · JAMA · doi:10.1001/jama.2019.0015 · Cited by 50

A new insight into adriamycin-induced cardiotoxicity

Fu, L.-X., Waagstein, F., & Hjalmarson, A. (1990) · International Journal of Cardiology · doi:10.1016/0167-5273(90)90267-9 · Cited by 49

The Preventive Role of Angiotensin Converting Enzyme Inhibitors/Angiotensin-II Receptor Blockers and β-Adrenergic Blockers in Anthracycline- and Trastuzumab-Induced Cardiotoxicity

Blanter, J., & Frishman, W. H. (2019) · Cardiology in Review · doi:10.1097/crd.0000000000000252 · Cited by 48

Transfusion Iron Overload in Adults with Acute Leukemia: Manifestations and Therapy

Barton, J. C., & Bertoli, L. F. (2000) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40691-3 · Cited by 46

Cardiac Protective Effect of Kirenol against Doxorubicin-Induced Cardiac Hypertrophy in H9c2 Cells through Nrf2 Signaling via PI3K/AKT Pathways

Alzahrani, A. M., Rajendran, P., Veeraraghavan, V. P., & Hanieh, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063269 · Cited by 46

Inhibition of mitochondrial carnitine palmitoyltransferases by adriamycin and adriamycin analogues

Kashfi, K., Israel, M., Sweatman, T. W., Seshadri, R., & Cook, G. A. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90438-q · Cited by 45

Natural Products and Drug Discovery

(2018) · Elsevier eBooks · doi:10.1016/c2016-0-02061-2 · Cited by 44

Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress

Zhao, D., Xue, C., Li, J., Feng, K., Zeng, P., Chen, Y., Duan, Y., Zhang, S., Li, X., Han, J., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.09.035 · Cited by 44

Hydrogen sulfide ameliorates doxorubicin‑induced myocardial fibrosis in rats via the PI3K/AKT/mTOR pathway

Nie, L., Liu, M., Chen, J., Wu, Q., Li, Y., Yi, J., Zheng, X., Zhang, J., Chu, C., & Yang, J. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.11938 · Cited by 44

Xanthine oxidase inhibition attenuates doxorubicin-induced cardiotoxicity in mice

Tanaka, Y., Nagoshi, T., Yoshii, A., Oi, Y., Takahashi, H., Kimura, H., Ito, K., Kashiwagi, Y., Tanaka, T. D., & Yoshimura, M. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.10.303 · Cited by 43

Melatonin prevents doxorubicin-induced cardiotoxicity through suppression of AMPKα2-dependent mitochondrial damage

Yang, G., Song, M., Hoang, D. H., Tran, Q. H., Choe, W., Kang, I., Kim, S. S., & Ha, J. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00541-3 · Cited by 43

Alteration of Matrix Metalloproteinases in Selective Left Ventricular Adriamycin-Induced Cardiomyopathy in the Pig

Goetzenich, A., Hatam, N., Zernecke, A., Weber, C., Czarnotta, T., Autschbach, R., & Christiansen, S. (2009) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2009.06.025 · Cited by 42

Heat Shock Protein 22 Attenuates Doxorubicin-Induced Cardiotoxicity via Regulating Inflammation and Apoptosis

Yin, L., Wang, Y., Huang, K., & Zeng, Q. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00257 · Cited by 42

Nitric Oxide Synthase Expressions in ADR-induced Cardiomyopathy in Rats

Liu, B., Li, H., Qu, H., & Sun, B. (2006) · BMB Reports · doi:10.5483/bmbrep.2006.39.6.759 · Cited by 40

Progress on the cardiotoxicity of sunitinib: Prognostic significance, mechanism and protective therapies

Yang, Y., & Bu, P. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.08.006 · Cited by 37

Schisandrin B improves cerebral ischemia and reduces reperfusion injury in rats through TLR4/NF-κB signaling pathway inhibition

Fan, X., Elkin, K. B., Shi, Y., Zhang, Z., Cheng, Y., Gu, J., Liang, J., Wang, C., & Ji, X. (2020) · Neurological Research · doi:10.1080/01616412.2020.1782079 · Cited by 37

Peptide Szeto‑Schiller 31 ameliorates doxorubicin‑induced cardiotoxicity by inhibiting the activation of the p38 MAPK signaling pathway

Zhang, L., Feng, M., Wang, X., Zhang, H., Ding, J., Cheng, Z., & Qian, L. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4896 · Cited by 37

Chemotherapy-Induced Cardiotoxicity: Pathophysiology and Prevention

Csapo, M., & Lazăr, L. (2014) · Medicine and Pharmacy Reports · doi:10.15386/cjmed-339 · Cited by 36

Anthracycline Cardiotoxicity

Menna, P., Salvatorelli, E., Gianni, L., & Minotti, G. (2007) · Topics in current chemistry · doi:10.1007/128_2007_11 · Cited by 34

METABOLISM OF THE ONE-RING OPEN METABOLITES OF THE CARDIOPROTECTIVE DRUG DEXRAZOXANE TO ITS ACTIVE METAL-CHELATING FORM IN THE RAT

Schroeder, P. E., & Hasinoff, B. B. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005546 · Cited by 33

Cardiotoxicity in Patients Treated With Bevacizumab Is Potentially Reversible

Hawkes, E. A., Okines, A. F. C., Plummer, C., & Cunningham, D. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.5008 · Cited by 33

Curcumin Attenuates Doxorubicin-Induced Cardiotoxicity by Inducing Autophagy via the Regulation of JNK Phosphorylation

Katamura, M. (2014) · Journal of Clinical & Experimental Cardiology · doi:10.4172/2155-9880.1000337 · Cited by 31

Potential targets for intervention against doxorubicin-induced cardiotoxicity based on genetic studies: a systematic review of the literature

Chen, Y., Huang, T., Shi, W., Fang, J., Deng, H., & Cui, G. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.11.150 · Cited by 31

New aspects in probucol cardioprotection against doxorubicin-induced cardiotoxicity

El‐Demerdash, E., Ali, A. A., Sayed‐Ahmed, M. M., & Osman, A. M. (2003) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0676-y · Cited by 29

Toxicology of Trastuzumab: An Insight into Mechanisms of Cardiotoxicity

An, J., & Sheikh, M. S. (2019) · Current Cancer Drug Targets · doi:10.2174/1568009618666171129222159 · Cited by 29

Protective Effect of Two Alkaloids from Hippophae rhamnoides Linn. against Doxorubicin-Induced Toxicity in H9c2 Cardiomyoblasts

Zhou, W., Ouyang, J., Hu, N., Li, G., & Wang, H. (2021) · Molecules · doi:10.3390/molecules26071946 · Cited by 29

Drug Induced Cardiotoxicity: Mechanism, Prevention and Management

Kelleni, M. T., & Abdelbasset, M. (2018) · InTech eBooks · doi:10.5772/intechopen.79611 · Cited by 28

Compound Danshen Dripping Pill inhibits doxorubicin or isoproterenol-induced cardiotoxicity

Feng, K., Liu, Y., Sun, J. M., Zhao, C.-L., Duan, Y., Wang, W., Yan, K., Yan, X., Sun, H., Hu, Y., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111531 · Cited by 28

MiR-181c protects cardiomyocyte injury by preventing cell apoptosis through PI3K/Akt signaling pathway

Li, X., Zhong, J., Zeng, Z., Wang, H., Li, J., Liu, X., & Yang, X. (2020) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-490 · Cited by 27

[Effect of curcumin on expression of survivin, Bcl-2 and Bax in human multiple myeloma cell line].

Liu, B., Bai, Q.-X., Chen, X., Gao, G., & Gu, H. (2007) · PubMed · Cited by 24

Xinmailong Attenuates Doxorubicin‐Induced Lysosomal Dysfunction and Oxidative Stress in H9c2 Cells via HO‐1

Jiang, Y., Liu, Y., Xiao, W. H., Zhang, D., Liu, X., Xiao, H., You, S., & Yuan, L. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5896931 · Cited by 24

Protective effects of pyrrolidine dithiocarbamate on myocardium apoptosis induced by adriamycin in rats

Li, H., Gu, H.-Y., & Sun, B. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.01.010 · Cited by 22

Tranilast prevents doxorubicin-induced myocardial hypertrophy and angiotensin II synthesis in rats

Zhan, C., Bai, N., Zheng, M., Wang, Y., Wang, Y., Zhang, L., Li, J., Li, G., Zhao, H., Liu, G., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118984 · Cited by 22

Erythropoietin Pretreatment Protects Against Acute Chemotherapy Toxicity in Isolated Rat Hearts

Ramond, A., Sartorius, E., Mousseau, M., Ribuot, C., & Joyeux‐Faure, M. (2008) · Experimental Biology and Medicine · doi:10.3181/0706-rm-152 · Cited by 21

Modeling Human Myocardium Exposure to Doxorubicin Defines the Risk of Heart Failure from Low-Dose Doxorubicin

Salvatorelli, E., Menna, P., Chello, M., Covino, E., & Minotti, G. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.242388 · Cited by 21

Diagnosis of Chemotherapy-Induced Cardiotoxicity

Pizzino, F., Vizzari, G., Bomzer, C. A., Qamar, R., Carerj, S., Zito, C., & Khandheria, B. K. (2014) · Journal of patient-centered research and reviews · doi:10.17294/2330-0698.1025 · Cited by 20

Human neuronal nitric oxide synthase can catalyze one-electron reduction of adriamycin: role of flavin domain

Fu, J., Yamamoto, K., Guan, Z., Kimura, S., & Iyanagi, T. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.04.030 · Cited by 20

Curcumin

Shehzad, A., Shahzad, R., & Lee, Y. S. (2014) · The Enzymes · doi:10.1016/b978-0-12-802215-3.00008-2 · Cited by 20

Role of Oxidation‐Dependent CaMKII Activation in the Genesis of Abnormal Action Potentials in Atrial Cardiomyocytes: A Simulation Study

Zhao, N., Li, Q., Sui, H., & Zhang, H. (2020) · BioMed Research International · doi:10.1155/2020/1597012 · Cited by 19

In vivo studies on adriamycin-induced lipid peroxidation and effects of ferrous ions.

Kappus, H., Muliawan, H., & Scheulen, M. E. (1980) · PubMed · Cited by 15

Possible protective effects of quercetin on doxorubicin-induced cardiotoxicity in rats

Hashish, F. R., Abdel-Wahed, M. M., Odemi, M. E., El-Naidany, S., & ElBatsh, M. M. (2021) · Menoufia Medical Journal · doi:10.4103/mmj.mmj_5_20 · Cited by 15

Nonlinear pharmacokinetics of visnagin in rats after intravenous bolus administration

Haug, K. G., Weber, B., Hochhaus, G., & Butterweck, V. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.10.023 · Cited by 13

Development of Chinese Herbal Health Products for the Prevention of Aging-Associated Diseases

Leong, P. K., Chen, J., & Ko, K. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-102081-4.00004-6 · Cited by 10

Cardioprotective effect of Malva verticillata against doxorubicin -induced toxicity in rats

Ibrahim, D. A., Almutawakel, M. A., & Albadani, R. N. (2021) · Clinical Phytoscience · doi:10.1186/s40816-021-00265-5 · Cited by 8

Research Methodologies and Practical Applications of Chemistry

Pogliani, L., Haghi, A. K., & Islam, N. (2019) · Apple Academic Press eBooks · doi:10.1201/9780429023460 · Cited by 6

Pharmacokinetics of Doxorubicin In Normal Weight and Obese Lymphoma Patients

Hoffmann, M. F., Bergner, R., Stützle, M., Uppenkamp, M. J., & Foerster, R. (2010) · Blood · doi:10.1182/blood.v116.21.4935.4935 · Cited by 3

Calycosin-triblock copolymer nanomicelles attenuate doxorubicin-induced cardiotoxicity through upregulation of ERp57

Wang, X., Zeng, L., Tu, S., Ye, F., & Zhang, Z. (2021) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2021.103142 · Cited by 3

Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity

Kciuk, M., Gielecińska, A., Mujwar, S., Kołat, D., Kałuzińska‐Kołat, Ż., Çeli̇k, İ., & Kontek, R. (2023) · Cells · doi:10.3390/cells12040659 · Cited by 906

Osteosarcoma

Beird, H. C., Bielack, S. S., Flanagan, A. M., Gill, J., Heymann, D., Janeway, K. A., Livingston, J. A., Roberts, R. D., Strauss, S. J., & Gorlick, R. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00409-y · Cited by 660

Gene therapy: Comprehensive overview and therapeutic applications

Sayed, N., Allawadhi, P., Khurana, A., Singh, V., Navik, U., Pasumarthi, S. K., Khurana, I., Banothu, A. K., Weiskirchen, R., & Bharani, K. K. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120375 · Cited by 365

Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches

Sheibani, M., Azizi, Y., Shayan, M., Nezamoleslami, S., Eslami, F., Farjoo, M. H., & Dehpour, A. R. (2022) · Cardiovascular Toxicology · doi:10.1007/s12012-022-09721-1 · Cited by 281

Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity

Wu, L., Wang, L., Du, Y., Zhang, Y., & Ren, J. T. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.10.003 · Cited by 261

Doxorubicin-induced phosphorylation of lamin A/C enhances DNMT1 and activates cardiomyocyte death via suppressing GATA-4 and Bcl-xL in rat heart

Tiwari, V., Salgar, S., Jorvekar, S. B., Kumbhar, B. M., Arava, S. K., Borkar, R. M., & Banerjee, S. K. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167692 · Cited by 5

Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity

Ferreira, A., Cunha‐Oliveira, T., Simões, R. F., Carvalho, F. S., Burgeiro, A., Nordgren, K. K. S., Wallace, K. B., & Oliveira, P. J. (2017) · Toxicology · doi:10.1016/j.tox.2017.08.011 · Cited by 78

Potential targets for intervention against doxorubicin-induced cardiotoxicity based on genetic studies: a systematic review of the literature

Chen, Y., Huang, T., Shi, W., Fang, J., Deng, H., & Cui, G. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.11.150 · Cited by 31

Pathophysiology of Doxorubicin-Mediated Cardiotoxicity

Arrigoni, R., Jirillo, E., & Caiati, C. (2025) · Toxics · doi:10.3390/toxics13040277 · Cited by 37

Mitigation of doxorubicin-induced cardiotoxicity by dichloroacetate: potential roles of restoration of PGC-1α/SIRT3 signaling and suppression of oxidative stress and apoptosis.

Saleh, M. F., El‐Sayad, M. E., & Goda, A. E. (2021) · PubMed · doi:10.26355/eurrev_202111_27100 · Cited by 6